Breaking News

Tweet TWEET

Urologix to Have National Presence at Upcoming AARP Life@50+ Event

Urologix to Have National Presence at Upcoming AARP Life@50+ Event

Urologix, the market leader for In-Office BPH Therapy, will be sponsoring the
educational session - Living With Frequent Urination? - Learn About Enlarged
Prostate Solutions at the upcoming AARP "Life@50+" National Event and Expo in
Atlanta.

MINNEAPOLIS, Minn., Sept. 30, 2013 (GLOBE NEWSWIRE) -- via PRWEB - Urologix,
Inc. (OTCQB:ULGX) will have a national presence at the upcoming AARP
"Life@50+" National Event and Expo being hosted in Atlanta at the Georgia
World Congress Center from October 3rd through October 5th. This semi-annual
event is expected to attract over 15,000 attendees and will include engaging
educational sessions and fun activities featuring world-class speakers and
entertainers. Urologix, the market leader for In-Office BPH Therapy, will be
sponsoring the educational session - Living With Frequent Urination? – Learn
About Enlarged Prostate Solutions. The Enlarged Prostate Solutions session
will take place on Saturday, October 5th at 1:00 PM ET at the Lifestyle Stage
2 and will feature Dr. Craig Smith, a board certified urologist at DuPage
Medical Group. Dr. Smith has extensive urologic experience and is considered
an expert in the area of In-Office BPH Therapies such as Cooled ThermoTherapy™
and Prostiva® RF Therapy. BPH (Benign Prostatic Hyperplasia) is the clinical
term for an enlarged prostate and is the most commonly diagnosed urological
problem in aging men. To find out more about non-surgical, in-office BPH
therapies, visit http://www.urologix.com.

"As men live into their 50's and beyond it is nearly inevitable that they will
develop some degree of urinary symptoms secondary to BPH. These symptoms will
most likely progress and often intervention becomes necessary," stated Dr.
Craig Smith, speaker for the AARP Enlarged Prostate Solutions session. "As
technology has advanced we are now able to provide same day, in-office,
minimally invasive procedures that do not require medication, have few side
effects and can result in years of sustainable results for our patients."

The Enlarged Prostate Solutions session will review common symptoms,
prevention, and treatment options for an Enlarged Prostate with a focus on
educating patients on In-Office BPH Therapies. This session promises to be a
very informative and valuable session for men who are currently experiencing
urinary symptoms as well as their significant others.

BPH affects the majority of men over the age of 50 and can create irritating
symptoms which significantly impact quality of life. Most patients are unaware
that there is a non-surgical option that may prevent them from having to take
medications for the rest of their lives. Urologix' office-based therapies such
as Cooled ThermoTherapy and Prostiva RF Therapy were first developed over 15
years ago and have evolved to be market leading non-surgical options. These
treatments are proven to be safe, effective and long-lasting options and are
included as recommended treatment options from the American Urology
Association guidelines.

Visit http://www.urologix.com to learn more about BPH and In-Office BPH
Therapy and learn why it is as an excellent alternative to chronic medication
therapy.

About Urologix

Urologix, Inc., based in Minneapolis, develops, manufactures, markets and
distributes minimally invasive medical products for the treatment of
obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). Urologix's
Cooled ThermoTherapy™ produces targeted microwave energy combined with a
unique cooling mechanism to protect healthy tissue and enhance patient
comfort. The Prostiva® RF Therapy System delivers radio frequency energy
directly into the prostate destroying prostate tissue, reducing constriction
of the urethra, and thereby relieving BPH symptoms. Both of these therapies
provide safe, effective and lasting relief of obstruction and symptoms due to
BPH. Prostiva is a registered trademark of Medtronic, Inc., used under
license. All other trademarks are the property of Urologix.

Federal USA law restricts these devices to sale by or on the order of a
physician. For more complete information about the benefits, risks and
contraindications associated with Cooled ThermoTherapy and Prostiva RF
Therapy, please refer to http://www.urologix.com.

If you would like more information on this topic, please contact Karen Snay at
513-484-2987 or ksnay(at)urologix(dot)com. To learn more about Urologix and
its products and services, visit http://www.urologix.com.

The Urologix logo and other media assets are available at
http://www.urologix.com/clinicians/resource-library.php.

Urologix Media Contact
Karen Snay
(513) 484-2987
Ksnay(at)urologix(dot)com

Urologix Investor Relations Contact
Brian Smrdel
(763) 475-7696
Bsmrdel(at)urologix(dot)com

This article was originally distributed on PRWeb. For the original version
including any supplementary images or video, visit
http://www.prweb.com/releases/2013/9/prweb11172547.htm

CONTACT: Urologix, Inc.
         Karen Snay
         ksnay@urologix.com
         +1 5134842987
 
Press spacebar to pause and continue. Press esc to stop.